 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 10/15/2018 |
$21.67 |
$22.00 |
$20.83 |
$21.28 |
1.50M | | 10/16/2018 |
$21.52 |
$23.20 |
$21.22 |
$22.92 |
3.72M | | 10/17/2018 |
$22.89 |
$23.20 |
$21.84 |
$22.87 |
1.90M | | 10/18/2018 |
$22.84 |
$23.05 |
$22.23 |
$22.73 |
2.80M | | 10/19/2018 |
$22.58 |
$23.48 |
$22.16 |
$22.21 |
4.94M |
|
|
| Acadia Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders. Co.'s portfolio of products includes its drug, NUPLAZID (pimavanserin), which has been approved by the U.S. Food and Drug Administration for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PD Psychosis). NUPLAZID is a selective serotonin inverse agonist preferentially targeting 5-HT2A receptors. In addition to PD Psychosis, Co.'s pipeline includes multiple product opportunities being explored in clinical development across several CNS disorders. | |
|
Acadia Pharmaceuticals (ACAD) has the following price history information. Looking back at ACAD historical stock prices for the last five trading days, on October 15, 2018, ACAD opened at $21.67, traded as high as $22.00 and as low as $20.83, and closed at $21.28. Trading volume was a total of 1.50M shares. On October 16, 2018, ACAD opened at $21.52, traded as high as $23.20 and as low as $21.22, and closed at $22.92. Trading volume was a total of 3.72M shares. On October 17, 2018, ACAD opened at $22.89, traded as high as $23.20 and as low as $21.84, and closed at $22.87. Trading volume was a total of 1.90M shares. On October 18, 2018, ACAD opened at $22.84, traded as high as $23.05 and as low as $22.23, and closed at $22.73. Trading volume was a total of 2.80M shares. On October 19, 2018, ACAD opened at $22.58, traded as high as $23.48 and as low as $22.16, and closed at $22.21. Trading volume was a total of 4.94M shares.
ACAD Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acadia Pharmaceuticals shares, starting with a $10,000 purchase of ACAD, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/20/2008 |
|
| End date: |
10/19/2018 |
|
| Start price/share: |
$2.00 |
|
| End price/share: |
$22.21 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
1,010.50% |
|
| Average Annual Total Return: |
27.21% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$111,044.97 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 10/15/2018 | $21.28 | | 10/16/2018 | $22.92 | | 10/17/2018 | $22.87 | | 10/18/2018 | $22.73 | | 10/19/2018 | $22.21 |
|
|
